Skip to main content
S 511 109th Congress Senate Health Abortion Administrative procedure Commerce Congress Congressional investigations Congressional reporting requirements Congressional veto Department of Health and Human Services Drug approvals Drugs Food and Drug Administration (FDA) Government Operations and Politics Government publicity Labeling Law

RU-486 Suspension and Review Act of 2005

Introduced: March 3, 2005 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 109th Congress ended
It never became law before the 109th Congress (2005–2006) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 3, 2005
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2020-2021)
Mar 3, 2005
Sponsor introductory remarks on measure. (CR S2020)
Mar 3, 2005
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

RU-486 Suspension and Review Act of 2005 - Deems the approved application for the drug mifepristone (marketed as Mifeprex, commonly known as RU-486, and used for the chemically induced termination of intrauterine pregnancy) to have been withdrawn.

Deems the drug misoprostol as misbranded under the Federal Food, Drug, and Cosmetic Act (FFDCA) if it bears labeling providing that the drug may be used for the medical termination of intrauterine pregnancy.

Directs the Comptroller General to review and report on the process by which the Food and Drug Administration (FDA) approved mifepristone. Provides for the reinstatement of the approved application for such drug if the report determines the approval to have been in accordance with FFDCA.

What's happening now March 3, 2005

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2020-2021)

 Related & companion bills 1
  • HR 1079 Related bill RU-486 Suspension and Review Act of 2005
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1
R
Thune, John
South Dakota · Sep 7, 2005
Cite this page click to expand
APA
U.S. Congress. (2026). S. 511: RU-486 Suspension and Review Act of 2005. 109th Congress. Open America. https://openamerica.io/bill/109-S-511/
MLA
"S. 511: RU-486 Suspension and Review Act of 2005." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-S-511/.
Bluebook (legal)
S. 511, 109th Cong. (2026), https://openamerica.io/bill/109-S-511/.
Markdown link
[S. 511: RU-486 Suspension and Review Act of 2005](https://openamerica.io/bill/109-S-511/)
Report a problem